LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

LLY

1,054.27

-0.65%↓

JNJ

209.54

-2.29%↓

ABBV

223.9

-1.64%↓

UNH

334.13

-2.12%↓

AZN

91.41

-0.2%↓

Начало・Списък с акции・Odonate Therapeutics Inc

O
Odonate Therapeutics Inc

Затворен

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Odonate Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

16.12.2025 г., 23:46 ч. UTC

Пазарно говорене

Gold Edges Higher, Aided by Fed Rate-Cut Prospects -- Market Talk

16.12.2025 г., 23:38 ч. UTC

Пазарно говорене

Nikkei May Rise on Possible Bargain-Hunting Interest -- Market Talk

16.12.2025 г., 22:35 ч. UTC

Придобивния, сливания и поглъщания

Santos: Sale Delivered Cash, Reduced Future Decommissioning Exposure

16.12.2025 г., 22:35 ч. UTC

Придобивния, сливания и поглъщания

Santos Sold 43% Stake in Petrel Fields, 100% of Tern Fields to Eni Australia

16.12.2025 г., 22:33 ч. UTC

Придобивния, сливания и поглъщания

Santos: A$40M Upfront Consideration, Up to A$20M in Contingent Payments

16.12.2025 г., 22:33 ч. UTC

Придобивния, сливания и поглъщания

Santos Sold 43% Operated Interest in Mahalo JV to Comet Ridge

16.12.2025 г., 22:32 ч. UTC

Придобивния, сливания и поглъщания

Santos Divests Two Noncore Assets as Part of Portfolio Optimization

16.12.2025 г., 22:25 ч. UTC

Придобивния, сливания и поглъщания

Westgold's Indicative Timetable Points to Early February Completion

16.12.2025 г., 22:24 ч. UTC

Придобивния, сливания и поглъщания

Westgold: Divestment Aligns With Broader Corporate Strategy

16.12.2025 г., 22:23 ч. UTC

Придобивния, сливания и поглъщания

Westgold: Deferred Payment Based on Performance Hurdles

16.12.2025 г., 22:23 ч. UTC

Придобивния, сливания и поглъщания

Westgold Will Receive A$15M Cash, A$19.6M in Alicanto Shares

16.12.2025 г., 22:23 ч. UTC

Придобивния, сливания и поглъщания

Westgold to Receive A$30M Deferred Payment in Cash or Shares

16.12.2025 г., 22:22 ч. UTC

Придобивния, сливания и поглъщания

Westgold Divesting Noncore Operating Asset for A$64.6M

16.12.2025 г., 22:22 ч. UTC

Придобивния, сливания и поглъщания

Westgold Agrees to Sell Mt Henry-Selene Project to Alicanto Minerals

16.12.2025 г., 21:53 ч. UTC

Печалби

Lennar Misses Earnings Estimates. The Stock Is Dropping. -- Barrons.com

16.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

16.12.2025 г., 21:33 ч. UTC

Придобивния, сливания и поглъщания

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- 2nd Update

16.12.2025 г., 21:18 ч. UTC

Придобивния, сливания и поглъщания

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- Update

16.12.2025 г., 21:17 ч. UTC

Придобивния, сливания и поглъщания

Worthington Enterprises to Buy LSI Group for About $205M >WOR

16.12.2025 г., 21:16 ч. UTC

Печалби

Worthington Enterprises 2Q Sales $327.5M >WOR

16.12.2025 г., 21:16 ч. UTC

Печалби

Worthington Enterprises 2Q Adj EPS 65c >WOR

16.12.2025 г., 21:16 ч. UTC

Печалби

Worthington Enterprises 2Q EPS 55c >WOR

16.12.2025 г., 21:15 ч. UTC

Придобивния, сливания и поглъщания

Worthington Enterprises Agrees To Acquire Leading Metal Roof Components Manufacturer LSI Group >WOR

16.12.2025 г., 21:05 ч. UTC

Придобивния, сливания и поглъщания

Ecolab Closes Acquisition Of Ovivo's Electronics Ultrapure Water Business >ECL

16.12.2025 г., 20:54 ч. UTC

Придобивния, сливания и поглъщания

Warner to Reject Paramount Offer As Soon As Wednesday, Sources Say -- WSJ

16.12.2025 г., 20:54 ч. UTC

Придобивния, сливания и поглъщания

Warner Preparing to Tell Shareholders to Reject Paramount Offer -- WSJ

16.12.2025 г., 20:54 ч. UTC

Придобивния, сливания и поглъщания

Warner to Recommend Existing Netflix Deal, Sources Say -- WSJ

16.12.2025 г., 20:44 ч. UTC

Пазарно говорене

Russia-Ukraine Peace Efforts Send Crude to Near 5-Year Low -- Market Talk

16.12.2025 г., 20:04 ч. UTC

Пазарно говорене

U.S. Natural Gas Extends Weather-Driven Losing Streak -- Market Talk

16.12.2025 г., 20:01 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

Сравнение с други в отрасъла

Ценова промяна

Odonate Therapeutics Inc Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

EBITDA

Оперативна печалба

Относно Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.